drugset / Trial / NCT01963728
Comparison of Insulin Therapy in Treating Post-Transplant Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine if the use of insulin isophane results in improved control of blood sugars compared to the use of insulin glargine in new onset diabetes after kidney, lung, or heart transplantation (NODAT).
Timeline
- Start
- 2013-11-27
- Primary completion
- 2015-04-09
- Completion
- 2015-04-09
Outcome
Outcome not reported
Stopped (Enrollment): “Blood sugar status of the enrolled subjects wasn't evaluable”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | insulin glargine | Protein / enzyme biologic | — | — |
| Comparator | insulin isophane | Unknown | — | — |